Couple gives $5.5 million to Ohio hospital

Sep 08, 2007

The University of Cincinnati College of Medicine has received a $5.5 million gift to establish a center for Parkinson's disease.

The gift to the University Hospital Foundation from the James J. and Joan A. Gardner Family Foundation will endow clinical and research programs while accelerating collaboration among scientists and physicians, the university said Friday in a release.

"We think it's important to come up with a cure for the disease, but also to do something to arrest the progression and research more medications," James Gardner, a retired executive at Cintas Corp., told The Cincinnati Enquirer.

Joan Gardner was diagnosed with Parkinson's disease several years ago, the newspaper said.

The James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders will be housed within the Neuroscience Institute at University Hospital.

"The Gardner Family endowment will propel Parkinson's disease research and care in Cincinnati to a new level of excellence and will encourage the broad collaboration of others," said Dr. John Tew, clinical director of the Neuroscience Institute.

Copyright 2007 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Testing roadkill badgers for bovine TB

Mar 06, 2014

(Phys.org) —Scientists at the University of Liverpool, in collaboration with farming groups and wildlife charities, are investigating the presence of bovine tuberculosis (bTB) in Cheshire wildlife by testing ...

Turbulent nature of menopause triggered by gene battles

Dec 10, 2013

The hormonal mayhem, reduced fertility and hot flushes experienced by a woman in the run up to menopause may owe to warfare between her own genes, according to a team of scientists working in the United Kingdom ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Fresh hope for preventing pneumonia in the elderly

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Phase transiting to a new quantum universe

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.

NASA image: Volcanoes in Guatemala

This photo of volcanoes in Guatemala was taken from NASA's C-20A aircraft during a four-week Earth science radar imaging mission deployment over Central and South America. The conical volcano in the center ...

When things get glassy, molecules go fractal

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...